Cardiovascular Systems Inc $ 46.71 0.81 (1.75%)
On watch
Volume:
24,656
Avg Vol (1m):
286,215
Market Cap $:
1.65 Bil
Enterprise Value $:
1.55 Bil
P/E (TTM):
0.00
P/B:
10.62
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
|
Price: $46.71 | ||
Manual of Stocks™ Web
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 5.85 | ||
| Equity-to-Asset | 0.68 | ||
| Debt-to-Equity | 0.14 | ||
| Debt-to-EBITDA | 4.14 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 13.74 | ||
| Beneish M-Score | -2.43 | ||
| WACC vs ROIC | |||
Profitability | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -0.33 | ||
| Net Margin % | -0.1 | ||
| ROE % | -0.19 | ||
| ROA % | -0.12 | ||
| ROC (Joel Greenblatt) % | 3.86 | ||
| 3-Year Revenue Growth Rate | 10.5 | ||
| 3-Year EPS without NRI Growth Rate | 82 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 10.62 | ||
| PS Ratio | 6.41 | ||
| Price-to-Free-Cash-Flow | 238.94 | ||
| Price-to-Operating-Cash-Flow | 155.55 | ||
| EV-to-EBIT | 955.75 | ||
| EV-to-EBITDA | 305.52 | ||
| EV-to-Revenue | 6.23 | ||
| Current Ratio | 4.25 | ||
| Quick Ratio | 3.83 | ||
| Days Inventory | 140.46 | ||
| Days Sales Outstanding | 53 | ||
| Days Payable | 85.69 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 11.02 | ||
| Price-to-Median-PS-Value | 1.6 | ||
| Earnings Yield (Greenblatt) % | 0.11 |